211 filings
Page 3 of 11
DEFA14A
4wgdvy64
15 Dec 05
Additional proxy soliciting materials
12:00am
424B7
tt5bven2 7h1gvjho
7 Dec 05
Prospectus with selling stockholder info
12:00am
8-K
w5d 6nrrwm
8 Nov 05
Other Events
12:00am
8-K
pipjx
25 Oct 05
Results of Operations and Financial Condition
12:00am
8-K
bytgtqns
27 Sep 05
Amendments to Articles of Incorporation or Bylaws
12:00am
424B3
x803 483n
29 Aug 05
Prospectus supplement
12:00am
POS AM
0u5d5frfhkrf33wync
22 Aug 05
Prospectus update (post-effective amendment)
12:00am
8-K
bsho 7h65fhlvlmq8
2 Aug 05
Abgenix and Amgen Announce Fda Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer
12:00am
8-K
y2x24 6igo
26 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
xco2meff5t
28 Jun 05
Cost Associated with Exit or Disposal Activities
12:00am
UPLOAD
7an1e
20 Jun 05
Letter from SEC
12:00am
424B3
cdmdc4xiy oh09
17 Jun 05
Prospectus supplement
12:00am
CORRESP
x5rdwgd3xxpl3d66
16 Jun 05
Correspondence with SEC
12:00am
CORRESP
xi10idtgq6v89n
16 Jun 05
Correspondence with SEC
12:00am
CORRESP
b8nvl t8x3wcf54bj8j0
8 Jun 05
Correspondence with SEC
12:00am
ARS
ad6h1 rc3ba78dpxn
9 May 05
Annual report to shareholders
12:00am